- OUTLOOK
Sparking an immune response where microbes enter the body should not only stop a person getting sick, but also prevent them spreading the infection to others.
By
-
Anthony King
-
Anthony King is a science writer in Dublin.
-
Vaccines created at the height of the COVID-19 pandemic prevented millions of deaths, especially among older people. But they fell short in stopping the spread of the virus.
Nature 657, S8-S9 (2026)
doi: https://doi.org/10.1038/d41586-026-02656-5
This article is part of Nature Outlook: Drug delivery, a supplement produced with financial support from Taiho Oncology, Inc. Nature maintains full independence in all editorial decisions related to the content. About this content.
References
Mitsi, E. et al. Nature Commun. 14, 6815 (2023).
Article PubMed Google Scholar
Stacey, H. D. et al. Sci. Transl. Med. 18, eadz8439 (2026).
Article PubMed Google Scholar
Nguyen, T. D. et al. Nature Commun. 16, 2871 (2025).
Article PubMed Google Scholar
Li, J. et al. Lancet Infect. Dis. 23, 1143–1152 (2023).
Article PubMed Google Scholar
Singh, C. et al. npj Vaccines 8, 125 (2023).
Article PubMed Google Scholar
Gbesemete, D. et al. Lancet Microbe 6, 101211 (2025).
Article PubMed Google Scholar
Download references
Related Articles
-
A good drug is useless if it misses its target
-
These six advances could change how drugs are delivered
-
Drug-delivering particles aim to breach the blood–brain barrier
-
Special delivery: bacterial couriers are smuggling drugs into cancers
-
Medicines do no good if people don’t take them
-
Drug delivery gets subcellular
-
Dose once, treat forever: drugs are being engineered to last much longer
-
Bacteria recruited to treat cancer
-
Partner content: Patient-centric drug delivery from Tahio Oncology: What does the future hold?
Subjects
Latest on:
- Vaccines
- Immunology
- Public health
-
Does the shingles vaccine cut heart-disease risk? Mounting evidence suggests a link
News
-
Systems vaccinology and the architecture of human immunity
Review Article
-
Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
News
-
Revealed: inside the US military’s plan to tap huge sums from the NIH
News
-
Immune therapy engineered inside the body eases multiple sclerosis
News
-
When do infections lead to long COVID? Scientists close in on triggers and treatments for post-viral syndromes
News Feature
-
A data leak shut a top research biobank: lessons from the recovery
News Feature
-
Scale of snakebites estimated globally
News & Views
-
AI models are being used to track zoonotic diseases. Will they prevent the next pandemic?
Technology Feature